Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center

Clinical Transplantation

Volumn 10, Issue 3, 1996, Pages 248-255

  Mihalov, M L ^a,c   Gatttiso, P ^b   Abraham, K ^b   Holmes, E W ^b   Reddy, V ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

Author keywords

OKT3; Organ transplantation; Post transplant lymphoproliferative disorder (PTLD); Post transplant malignancy

Indexed keywords

OKT 3; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CANCER INCIDENCE; HEART GRAFT; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LIP CANCER; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEART NEOPLASMS; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; LIP NEOPLASMS; LUNG NEOPLASMS; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MUROMONAB-CD3; NEOPLASMS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; SKIN NEOPLASMS;

EID: 9344242356     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. PENN I. Depressed immunity and the development of cancer. Clin Exp Immunol 1981; 46: 459.
2. PENN I. Tumors after renal and cardiac transplantation. Hematol/Oncol Clin N Am 1993; 7 (2): 431.
3. PENN I. Occurrence of cancer in immunosuppressed organ transplant recipients. In: TERASAKI P, ed. Clinical Transplants; ed: Terasaki P. 1990: 53.
4. PENN I. Why do immunosuppressed patients develop cancer. In: PIMENTAL E, ed. Critical Reviews of Oncogenesis. 1989: 27.
5. GUPTA AK, CARDELLA CJ, HABERMAN HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1985; 122: 1288.
6. PENN I. The changing patterns of post-transplant malignancies. Trans Proc 1991; 23: 1101.
7. KINLEN LJ, SHEIL AGR, PETO J, DOLL R. Collaborative United Kingdom-Australian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979; 2: 1461.
8. KINLEN LJ. Immunosuppressive therapy and cancer. Cancer Surv 1982; 1: 565.
9. NALESNIK MS, JAFFEE R, STARZL TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporin A - prednisone immunosuppression. Am J Clin Path 1988; 133: 173.
10. FERRY JA, JACOBSON JO, CONTI D, et al. Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Modern Path 1989; 2: 583.
11. STARZL TE, NALESNIK MA, PORTER KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin - steroid therapy. Lancet 1984; 1: 583.
12. SWINNEN LJ, CONSTANZO-NORDIN MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990; 323: 1723.
13. YOUSSEM SA, RANDHAWA P, LOCKER J, et al. Post transplant lymphoproliferative disorders in heart-lung recipients. Hum Pathol 1989; 20: 361.
14. GRUBER SA, SKJEI KL, SOTHERN RB, et al. Cancer development in renal allograft recipients treated with conventional and cyclosporin immunosuppression. Transpl Proc 1991; 23: 1104.
15. LAWLESS JF. Survival Analysis. Statistical Models and Methods for Lifetime Data., New York: Wiley, 1982.
16. ARMITAGE JM, KORMOS, RL, STUARt RS, et al. Post-transplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporin-based immunosuppression. J Heart Lung Transpl 1991; 10: 877.
17. GRATTAN, MT, MORENO-CABRAl CE, STARUES, VA, et al. Eight-year results of cyclosporin-treated patients with cardiac transplant. J Thorac Cardiovasc Surg 1990; 99: 500.
18. BRUMBAUGH J, BALDWIN JC, STINSON EB, et al. Quantitative analysis of immunosuppression in cyclosporin-treated heart transplant patients with lymphoma and heart transplantation. 1985; 4: 307.
19. BERNSTERN D, BAUM D, BERRY G, et al. Neoplastic disorders after pediatric heart transplantation. Circulation 1993; 88: 230.
20. COCHFIELD SM, PREIKSAITIS J, HARVEY E, et al. Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant post-transplant lymphoproliferative disorder? Trans Proc 1991; 23: 1106.